Home / GlobeNewswire

HeartCore Reports Third Quarter 2026 Financial Results

NEW YORK and TOKYO, Nov. 16, 2026 (GLOBE NEWSWIRE) -- HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or the “Company”), an IPO consulting services company based in Tokyo, reported financial results for the third quarter and nine months ended September 30, 2026.

Recent Operational Highlights

  • Entered into a non-exclusive business development and sales agency agreement in Japan with ONE AI, Co., Ltd. (“ONE AI”)
  • As of September 30, 2026, HeartCore was engaged with 16 Go IPO clients, including 6 clients currently in various stages of preparation for potential initial public offerings and U.S. exchange listings.
  • Announced and completed the transfer of the Company’s 51% equity interest in HeartCore Luvina Vietnam Company Limited (“HeartCore Luvina”) to Luvina Software Joint Stock Company for JPY 29,000,000 (approximately $184,000). Together with the June 2026 divestiture of Sigmaways, Inc., the transaction concludes the Company’s exit from software development services and concentrates its operations on Go IPO consulting, capital markets advisory, and financial services.

Management Commentary
HeartCore CEO Sumitaka Kanno commented: “With the transfer of our interest in HeartCore Luvina completed during the third quarter, we have concluded the portfolio optimization we began earlier this year. HeartCore now operates as a focused Go IPO consulting, capital markets advisory, and financial services company, which we believe allows us to direct management attention and capital toward the areas where we see the greatest long-term opportunity.

“The Nasdaq listing environment remains selective, and a number of our clients have extended their IPO timelines as they work to satisfy stricter exchange and regulatory requirements. We continue to prioritize clients that we believe demonstrate stronger fundamentals, organizational readiness, and a clear path to a U.S. listing, and we are cautiously optimistic that this disciplined approach will support a higher-quality pipeline over time.

“Beyond our core business, just last week, we announced a new business development and sales agency agreement with ONE AI. Under this agreement, we will support ONE AI’s commercial expansion into the Japanese robotics market. Importantly, the agreement introduces an additional commission-based revenue stream, further diversifying our revenue base as we continue to navigate the current U.S. listing environment.

“Looking ahead, we intend to maintain disciplined cost management as we work to convert our pipeline into new engagements and listing milestones. With a simpler structure in place, we expect our results going forward to more clearly reflect the performance of our core business.”

Third Quarter 2026 Financial Results
Revenues were $162,000 compared to $1.2 million in the same period last year. The decrease was primarily due to fewer Go IPO consulting clients and fewer successful client IPOs during the period.

Gross profit was $16,000 compared to $1.1 million in the same period last year. The decrease reflected lower Go IPO consulting revenues and higher consulting service costs, including increased outsourcing fees.

Operating expenses were $1.2 million compared to $899,000 in the same period last year. The increase was primarily due to higher general and administrative expenses, including salaries and benefits, restructuring-related consulting and professional fees, and rent, partially offset by lower selling expenses.

Net loss was $596,000 compared to net income of $351,000 in the same period last year. The change reflected lower gross profit, higher operating expenses, and a shift from income to a loss from discontinued operations, partially offset by net other income and an income tax benefit.

Adjusted EBITDA was $(1.1) million for the third quarter of 2026 compared to Adjusted EBITDA of $0.4 million in the same period last year.

Nine Months Ended September 30, 2026 Financial Results
Revenues were $270,000 compared to $1.7 million in the same period last year. The decrease was primarily due to fewer Go IPO consulting clients and fewer successful client IPOs during the period.

Gross loss was $260,000 compared to gross profit of $1.3 million in the same period last year. The change reflected lower Go IPO consulting revenues and higher service costs, including increased resources devoted to client service and higher outsourcing fees.

Operating expenses were $3.1 million compared to $2.8 million in the same period last year. The increase was primarily due to higher general and administrative expenses, including salaries and benefits, rent, and restructuring-related consulting and professional fees, partially offset by lower selling expenses and reductions in certain other administrative costs.

Net loss was $3.8 million compared to a net loss of $1.7 million in the same period last year. The increase reflected a shift from gross profit to gross loss, higher operating expenses, and a loss from discontinued operations compared to income in the prior-year period, partially offset by lower net other expenses and an income tax benefit.

Adjusted EBITDA was $(3.2) million for the nine months ended September 30, 2026, compared to Adjusted EBITDA of $(0.8) million in the same period last year.

As of September 30, 2026, the Company had cash and cash equivalents of $1.0 million compared to $1.5 million as of December 31, 2025.

About HeartCore Enterprises, Inc.
HeartCore Enterprises, Inc. is headquartered in Tokyo, Japan, and is a leading consulting services company providing U.S. market listing support and related advisory services primarily to Japanese corporate clients. For more information, please visit https://heartcore-enterprises.com/.

Non-GAAP Financial Measures
This document includes references to Adjusted EBITDA, which is a non-GAAP financial measure. For the purposes of this presentation, Adjusted EBITDA is calculated by adjusting net loss to exclude depreciation and amortization, changes in fair value of investments in marketable securities, changes in fair value of investment in warrants, changes in fair value of derivative liability, interest income, interest expenses, other income, and other expenses.

This measure is presented as supplemental information and is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with accounting principles generally accepted in the U.S. (“GAAP”).

Management believes that Adjusted EBITDA provides useful information to investors by highlighting the Company’s core operational performance, excluding non-cash and non-recurring items. However, non-GAAP financial measures have limitations and should not be considered in isolation or as a substitute for financial results prepared in accordance with GAAP.

For the three months ended September 30,

Item20262025
Net income (loss)$(0.6) million$0.4 million
(+) Depreciation$0.0 million$0.0 million
(+) Changes in fair value of investments in marketable securities$(0.4) million$(0.0) million
(+) Changes in fair value of investment in warrants$(0.0) million$0.1 million
(+) Changes in fair value of derivative liability$0.0 million$0.0 million
(+) Interest income$(0.0) million$(0.0) million
(+) Interest expenses$0.0 million$0.0 million
(+) Other income$(0.2) million$(0.0) million
(+) Other expenses$0.0 million$0.0 million
Adjusted EBITDA$(1.1) million$0.4 million

For the nine months ended September 30,

Item20262025
Net loss$(3.8) million$(1.7) million
(+) Depreciation$0.0 million$0.0 million
(+) Changes in fair value of investments in marketable securities$0.4 million$0.9 million
(+) Changes in fair value of investment in warrants$0.0 million$0.1 million
(+) Changes in fair value of derivative liability$0.0 million$0.0 million
(+) Interest income$(0.0) million$(0.0) million
(+) Interest expenses$0.0 million$0.0 million
(+) Other income$(0.2) million$(0.0) million
(+) Other expenses$0.4 million$0.0 million
Adjusted EBITDA$(3.2) million$(0.8) million

Note: Figures in the tables above are rounded to the nearest $0.1 million; therefore, totals may not sum due to rounding.

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, or the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts included in this press release are forward-looking statements. In some cases, forward-looking statements can be identified by words such as “believed,” “intend,” “expect,” “anticipate,” “plan,” “potential,” “continue,” or similar expressions. Such forward-looking statements include risks and uncertainties, and there are important factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These factors, risks, and uncertainties are discussed in HeartCore’s filings with the Securities and Exchange Commission. Investors should not place any undue reliance on forward-looking statements since they involve known and unknown, uncertainties and other factors which are, in some cases, beyond HeartCore’s control which could, and likely will materially affect actual results, and levels of activity, performance, or achievements. Any forward-looking statement reflects HeartCore’s current views with respect to future events and is subject to these and other risks, uncertainties, and assumptions relating to operations, results of operations, growth strategy, and liquidity. HeartCore assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The contents of any website referenced in this press release are not incorporated by reference herein.

HeartCore Investor Relations Contact:
Gateway Group, Inc.
John Yi and Steven Shinmachi
HTCR@gateway-grp.com
(949) 574-3860


      
 HEARTCORE ENTERPRISES, INC.
 UNAUDITED CONSOLIDATED BALANCE SHEETS
      
   September 30, December 31,
   2026  2025 
 ASSETS
 Current assets:    
 Cash and cash equivalents$976,594 $1,530,967 
 Accounts receivable 32,853  - 
 Investments in marketable securities 1,380,553  3,690,187 
 Prepaid expenses 82,351  127,242 
 Deferred offering costs 250,000  250,000 
 Other current assets 144,079  188,525 
 Current assets of discontinued operations -  1,337,673 
 Proceeds receivable from sale of discontinued operations 483,082  1,291,298 
 Total current assets 3,349,512  8,415,892 
      
 Non-current assets:    
 Property and equipment, net 255,872  275,465 
 Operating lease right-of-use assets 352,524  16,986 
 Long-term investment in warrants 130,916  280,924 
 Long-term loan receivable 258,859  - 
 Deferred tax assets 23,006  23,121 
 Security deposits 276,199  278,342 
 Other non-current assets 286  - 
 Non-current assets of discontinued operations -  33,752 
 Long-term proceeds receivable from sale of discontinued operations 3,496,039  3,736,995 
 Total non-current assets 4,793,701  4,645,585 
      
 Total assets$8,143,213 $13,061,477 
      
 LIABILITIES AND SHAREHOLDERS' EQUITY
 Current liabilities:    
 Accounts payable and accrued expenses$454,345 $275,412 
 Accrued payroll and other employee costs 41,859  41,073 
 Due to related party 423  285 
 Insurance premium financing 33,736  13,430 
 Operating lease liabilities, current 284,622  16,986 
 Income tax payables 20,564  1,038 
 Deferred revenue 438,862  676,216 
 Derivative liability 62,507  121,719 
 Other current liabilities 530,070  521,607 
 Current liabilities of discontinued operations -  1,833,294 
 Total current liabilities 1,866,988  3,501,060 
      
 Non-current liabilities:    
 Operating lease liabilities, non-current 71,912  - 
 Deferred tax liabilities 211,795  1,039,181 
 Non-current liabilities of discontinued operations -  448,376 
 Total non-current liabilities 283,707  1,487,557 
      
 Total liabilities 2,150,695  4,988,617 
      
 Shareholders' equity:    
 Preferred shares, $0.0001 par value, 20,000,000 shares authorized; Series A convertible preferred shares, 4,000 shares designated, 517 and 1,017 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively; aggregate liquidation preference of $617,916 and $1,158,362 as of September 30, 2026 and December 31, 2025, respectively 351,712  691,858 
 Common shares, $0.0001 par value, 200,000,000 shares authorized, 1,515,328 and 1,270,991 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively* 151  127 
 Additional paid-in capital 22,309,504  21,902,169 
 Accumulated deficit (16,640,902) (12,965,525)
 Accumulated other comprehensive loss (27,947) (58,497)
 Total HeartCore Enterprises, Inc. shareholders' equity 5,992,518  9,570,132 
 Non-controlling interests -  (1,497,272)
 Total shareholders' equity 5,992,518  8,072,860 
      
 Total liabilities and shareholders' equity$8,143,213 $13,061,477 
      



        
 HEARTCORE ENTERPRISES, INC. 
 UNAUDITED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) 
        
   For the Nine Months 
   Ended September 30, 
   2026   2025  
 Revenues$269,852  $1,666,519  
 Cost of revenues 529,562   331,962  
 Gross profit (loss) (259,710)  1,334,557  
        
 Operating expenses:      
 Selling expenses 104,021   296,632  
 General and administrative expenses 2,986,544   2,488,822  
 Total operating expenses 3,090,565   2,785,454  
        
 Income (loss) from continuing operations (3,350,275)  (1,450,897) 
        
 Other income (expenses):      
 Changes in fair value of investments in marketable securities (375,367)  (908,416) 
 Changes in fair value of investment in warrants (7,493)  (74,109) 
 Changes in fair value of derivative liability (630)  (9,679) 
 Interest income 1,100   3,966  
 Interest expenses (6,386)  (8,569) 
 Other income 186,056   45,632  
 Other expenses (361,838)  (193) 
 Total other income (expenses) (564,558)  (951,368) 
        
 Income (loss) from continuing operations before income tax expense (benefit) (3,914,833)  (2,402,265) 
 Income tax expense (benefit) (766,504)  33,377  
 Net income (loss) from continuing operations (3,148,329)  (2,435,642) 
 Income (loss) from discontinued operations, net of income tax (644,329)  710,942  
 Net income (loss) (3,792,658)  (1,724,700) 
 Less: income (loss) from discontinued operations attributable to non-controlling interests (117,281)  (171,682) 
 Net income (loss) attributable to HeartCore Enterprises, Inc. (3,675,377)  (1,553,018) 
 Dividends accrued on Series A convertible preferred shares (62,530)  (56,833) 
 Net income (loss) attributable to HeartCore Enterprises, Inc. common shareholders$(3,737,907) $(1,609,851) 
        
 Other comprehensive income (loss):      
 Foreign currency translation adjustment (72,706)  9,668  
 Cumulative translation adjustment reclassified into earnings due to disposal of discontinued operations 94,751   -  
 Total comprehensive income (loss) (3,770,613)  (1,715,032) 
 Less: comprehensive income (loss) attributable to non-controlling interests(125,786)  (175,353) 
 Comprehensive income (loss) attributable to HeartCore Enterprises, Inc.$(3,644,827) $(1,539,679) 
        
 Net income (loss) from continuing operations attributable to HeartCore Enterprises, Inc. per common share*      
 Basic$(2.30) $(2.22) 
 Diluted$(2.30) $(2.22) 
        
 Income (loss) from discontinued operations per common share*      
 Basic$(0.38) $0.78  
 Diluted$(0.38) $0.78  
        
 Net income (loss) attributable to HeartCore Enterprises, Inc. per common share*    
 Basic$(2.68) $(1.43) 
 Diluted$(2.68) $(1.43) 
        
 Weighted average common shares outstanding*      
 Basic 1,395,177   1,124,484  
 Diluted 1,395,177   1,124,484  
        



       
 HEARTCORE ENTERPRISES, INC. 
 UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS 
       
   For the Nine Months 
   Ended September 30, 
   2026  2025  
 Cash flows from operating activities of continuing operations:     
 Net loss$(3,792,658)$(1,724,700) 
 Income (loss) from discontinued operations, net of income tax (644,329) 710,942  
 Net loss from continuing operations (3,148,329) (2,435,642) 
 Adjustments to reconcile net loss from continuing operations to net cash flows used in operating activities of continuing operations:     
 Depreciation expense 23,023  36,994  
 Loss on disposal of property and equipment -  116,981  
 Non-cash lease expense 195,691  28,167  
 Gain on termination of lease -  (9,059) 
 Deferred income taxes (796,046) 29,680  
 Stock-based compensation 2,031  69,222  
 Warrants received as noncash consideration -  (837,913) 
 Changes in fair value of investments in marketable securities 375,367  908,416  
 Changes in fair value of investment in warrants 7,493  74,109  
 Changes in fair value of derivative liability 630  9,679  
 Gain on settlement of asset retirement obligations -  (45,873) 
 Changes in assets and liabilities:     
 Accounts receivable (32,826) -  
 Prepaid expenses 152,391  114,556  
 Other assets 93,367  137,050  
 Accounts payable and accrued expenses 178,373  (98,030) 
 Accrued payroll and other employee costs 988  (43,430) 
 Due to related party 138  -  
 Operating lease liabilities (191,710) (21,135) 
 Income tax payables 19,382  (97,537) 
 Deferred revenue (237,354) (278,421) 
 Other liabilities 8,458  (4) 
 Net cash flows used in operating activities of continuing operations (3,348,933) (2,342,190) 
       
 Cash flows from investing activities of continuing operations:     
 Purchases of property and equipment (4,931) -  
 Proceeds from sale of marketable securities 2,076,782  1,071,732  
 Advances on loan receivable (256,932) -  
 Proceeds from sales of discontinued operations, net of cash divested 825,663  -  
 Net cash flows provided by investing activities of continuing operations 2,640,582  1,071,732  
       
 Cash flows from financing activities of continuing operations:     
 Payments for finance lease -  (12,692) 
 Repayment of insurance premium financing (87,694) (103,303) 
 Proceeds from issuance of common shares related to at the market offering agreement -  30,445  
 Proceeds from collection of subscription receivable -  103,942  
 Proceeds from exercise of stock options -  117,000  
 Proceeds from issuance of Series A convertible preferred shares and common shares related to securities purchase agreement, net of share issuance costs -  1,800,000  
 Net cash flows provided by (used in) financing activities of continuing operations (87,694) 1,935,392  
       
 Cash flows from discontinued operations:     
 Net cash flows used in operating activities of discontinued operations (119,498) (511,096) 
 Net cash flows provided by (used in) investing activities of discontinued operations(1,432) 29,222  
 Net cash flows used in financing activities of discontinued operations (22,134) (305,990) 
 Net cash flows used in discontinued operations (143,064) (787,864) 
       
 Effect of exchange rate changes (70,259) 26,577  
       
 Net change in cash and cash equivalents (1,009,368) (96,353) 
 Cash and cash equivalents - beginning of the period 1,985,962  2,121,089  
 Cash and cash equivalents - end of the period$976,594 $2,024,736  
       
 Supplemental cash flow disclosures:     
 Interest paid$32,583 $88,321  
 Income taxes paid$14,197 $131,118  
       
 Non-cash investing and financing transactions:     
 Insurance premium financing$108,000 $139,500  
 Warrants converted to marketable securities$142,515 $388,260  
 Operating lease right-of-use assets obtained in exchange for operating lease liabilities$552,577 $23,495  
 Issuance of common shares related to equity purchase agreement$- $250,000  
 Dividends accrued on Series A convertible preferred shares$62,530 $56,833  
 Issuance of common shares for dividends on Series A convertible preferred shares$67,870 $-  
 Series A convertible preferred shares converted to common shares$340,146 $-  
       



Source: GlobeNewswire

Leave a comment

Comments are closed on this post.

Related